Plasma aldosterone concentration in the patient with diabetes mellitus

Norman K Hollenberg1, Radomir Stevanovic, Anupam Agarwal

  • 1Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. djpagecapo@rics.bwh.harvard.edu

Kidney International
|April 17, 2004
PubMed
Abstract

Insights

Patients with type 1 diabetes mellitus exhibit elevated aldosterone levels due to renin-system activation. Blocking the renin-angiotensin system (RAS) may help manage vascular injury in these patients.

Area of Science:

  • Endocrinology
  • Cardiovascular Research
  • Metabolic Diseases

Background:

  • Vascular injury is a significant complication in diabetes mellitus.
  • Renin-system activation is observed in type 1 diabetes, suggesting a role for aldosterone in vascular damage.

Purpose of the Study:

  • To investigate the renin-angiotensin-aldosterone system (RAAS) in type 1 diabetes mellitus patients.
  • To determine if RAAS activation contributes to vascular complications in diabetes.

Main Methods:

  • Studied 58 type 1 diabetes patients and 64 controls.
  • Maintained fixed sodium and potassium intake.
  • Collected samples at a consistent time to minimize circadian rhythm effects.

Main Results:

  • Type 1 diabetes patients showed increased plasma renin activity, angiotensin II, and aldosterone concentrations.
  • Angiotensin receptor blocker (candesartan) significantly impacted aldosterone levels, confirming renin-system involvement.
  • Elevated aldosterone in diabetes is linked to renin-system activation.

Conclusions:

  • Pharmacological interruption of aldosterone's effects may benefit diabetes patients.
  • Adjusting renin-angiotensin system (RAS) blocking agents is crucial for maximizing aldosterone reduction.

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...